Yes. We offer GMP-compliant fill finish services for viral vectors, allogeneic cell therapies, and other small-batch biologics. Our fill finish suite includes a Grade C cleanroom and Grade A isolator, suitable for clinical-stage vial or bag filling. We provide this as a standalone service or integrated within a broader manufacturing programme, with full GMP oversight […]
Apr 11, 2025
Can we support fill finish?
Yes. We offer GMP-compliant fill finish services for viral vectors, allogeneic cell therapies, and other small-batch biologics. Our fill finish suite includes a Grade C cleanroom and Grade A isolator, suitable for clinical-stage vial or bag filling. We provide this as a standalone service or integrated within a broader manufacturing programme, with full GMP oversight and documentation.
Latest News
FDA’s CGT Flexibilities: Clarity for Developers, Complexity for Strategy
Mar 20, 2026
Blog
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer to strengthen global commercial strategy
Mar 3, 2026
Industry News
Lucy Foley appointed to BioPhorum Strategic Advisory Board
Feb 6, 2026
Industry News
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.